Total (N = 270) | HIV infected (N = 123) | HIV non-infected (N = 147) | |
---|---|---|---|
Histology | |||
Squamous Cell Carcinoma | 251 (93) | 117 (95.1) | 134 (91.2) |
Adenocarcinoma | 16 (5.9) | 4 (3.3) | 12 (8.2) |
No histology available | 3 (1.1) | 2 (1.6) | 1 (0.7) |
Disease severity stage | |||
Early stage I-IIA | 28 (10.4) | 16 (13.0) | 12 (8.2) |
Advanced stage IIB-IIIB | 152 (56.3) | 71 (57.7) | 81 (55.1) |
Late stage IV | 5 (1.9) | 1 (0.8) | 4 (2.7) |
Missing information | 85 (31.5) | 35 (28.5) | 50 (34.0) |
Age at diagnosis in years, median (range) | 49.8 (21–87) | 44.8 (21–76) | 55.9 (31–87) |
Marital Status | |||
Single | 45 (1.9) | 3 (2.6) | 1 (0.7) |
Married | 147 (54.4) | 55 (48.3) | 87 (59.2) |
Widowed | 103 (38.2) | 48 (42.1) | 52 (35.4) |
Divorced or separated | 15 (5.6) | 7 (6.1) | 7 (4.8) |
Pregnancies & Birth | |||
Gravidity, median (range) | 6 (0–23) | 4 (0–13) | 7 (0–23) |
Parity, median (range) | 5 (0–20) | 4 (0–12) | 6 (0–20) |
Education | |||
No education | 106 (39.3) | 27 (22) | 79 (53.7) |
Basic education | 153 (56.7) | 89 (72.4) | 64 (43.5) |
Advanced education | 11 (4.1) | 7 (5.7) | 4 (2.7) |
Antiretroviral treatment (ART) | |||
On ART | 88 (71.6) | ||
-Years on ART, median (range) | 4,5 (0–20) | ||
- < 1 year on ART | 15 (12.2) | ||
- ≥ 1 year on ART | 62 (50.4) | ||
Not on ART | 23 (18.7) | ||
Not known | 12 (9.8) | ||
CD4 Counts | |||
Recent CD4 count, median (range) | 365 (11–1226) | ||
- ≤ 200 cells/µl | 25 (20.3) | ||
-200–349 cells /µl | 31 (25.2) | ||
- ≥ 350 cells /µl | 68 (55.3) | ||
Lowest CD4 count, median (range) | 231 (5–1158) | ||
- < 200 cells /µl | 48 (39) | ||
CD4 cell count not known | 5 (4.1) | ||
WHO Stages | |||
Stages 1–2 | 90 (73,2) | ||
Stages 3–4 | 19 (15.5) | ||
Not known | 14 (11.4) | ||
Clinical Presentation | |||
Any symptoms | 249 (92.2) | 110 (89,4) | 139 (94.6) |
No symptoms | 21 (7.8) | 13 (10,6) | 8 (5.4) |
Lower abdominal pain | 177 (65.6) | 79 (64,2) | 98 (66.7) |
Abnormal vaginal discharge | 223 (82.6) | 96 (78.1) | 127 (86.4) |
Abnormal menstrual bleeding | 62 (23) | 34 (27.6) | 28 (19.1) |
-Intermenstrual bleeding | 39 (14.4) | 27 (22) | 12 (8.2) |
-Prolonged menstrual bleeding | 29 (10.7) | 10 (8.1) | 19 (12.9) |
Sexually active | N = 85 | N = 46 | N = 39 |
-Post-coital bleeding | 60 (70.6) | 34 (73.9) | 26 (66.7) |
-Pain during sex | 70 (82.4) | 38 (82.6) | 32 (82.1) |